Carmelo Sgobio
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Striatal dopamine neurotransmission is altered in age- and region-specific manner in a Parkinson's disease transgenic mouse.
Journal: Scientific reports
Published: October 01, 2023
Deficiency of Perry syndrome-associated p150Glued in midbrain dopaminergic neurons leads to progressive neurodegeneration and endoplasmic reticulum abnormalities.
Journal: NPJ Parkinson's disease
Published: October 04, 2022
β-secretase inhibition prevents structural spine plasticity deficits in App NL-G-F mice.
Journal: Frontiers in aging neuroscience
Published: March 31, 2022
Selective expression of neurodegenerative diseases-related mutant p150Glued in midbrain dopaminergic neurons causes progressive degeneration of nigrostriatal pathway.
Journal: Ageing and neurodegenerative diseases
Published: January 01, 2022
Impact of α-synuclein spreading on the nigrostriatal dopaminergic pathway depends on the onset of the pathology.
Journal: Brain pathology (Zurich, Switzerland)
Published: April 29, 2021
Cortical circuit dysfunction in a mouse model of alpha-synucleinopathy in vivo.
Journal: Brain communications
Published: January 13, 2021
Loss of fragile X mental retardation protein precedes Lewy pathology in Parkinson's disease.
Journal: Acta neuropathologica
Published: August 27, 2019
Tau deletion reduces plaque-associated BACE1 accumulation and decelerates plaque formation in a mouse model of Alzheimer's disease.
Journal: The EMBO journal
Published: April 29, 2019
Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second-Generation Amyloid-β Mouse Model.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: February 12, 2019
Unbalanced calcium channel activity underlies selective vulnerability of nigrostriatal dopaminergic terminals in Parkinsonian mice.
Journal: Scientific reports
Published: November 23, 2018
Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 02, 2017
Last Updated: 09/26/2026